Seventeen percent of ACPA‐seropositive patients with RA in the MUCOSA study had detectable ACPA IgA in saliva, whereas ACPA could not be detected in the saliva of patients who were ACPA seronegative or healthy donors (Figure 1A) (not significant [ns]). This evidence concerns the gene CD79A and rheumatoid arthritis.